Health Topics – Johns Hopkins Medicine Podcasts
Jul 3, 2026 · 1 min · 3 segments
GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity…
Elizabeth TracyThe risks for cancers associated with obesity also seems to be going up and appearing in younger age groups.
There's already a little bit of a hint that when these drugs are taken for obesity, not for diabetes, they may impact the risk of obesity-related cancers.
They
to find non-diabetic patients
no history of cancer between 2014, that's really when these drugs started to be used for obesity, and 2025.
The risks for cancers associated with obesity also seems to be going up and appearing in younger age groups.
There's already a little bit of a hint that when these drugs are taken for obesity, not for diabetes, they may impact the risk of obesity-related cancers.
They
to find non-diabetic patients
no history of cancer between 2014, that's really when these drugs started to be used for obesity, and 2025.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
